Free Consultation (800) 424-6690 Free Consultation (800) 424-6690 | [email protected]

Newsroom Search

featured news

September 9, 2015 Healthcare Fraud

The Growing Problem of Data Falsification by Overseas Drug Manufacturers

In yesterday’s post, we reviewed a controversial phenomenon plaguing the international drug market involving the production of substandard generic medications in India. More specifically, we looked at how patients in America and worldwide could face harm by taking drugs manufactured by companies like Ranbaxy, as studies have revealed that key […]
September 8, 2015 Healthcare Fraud

Potential Dangers Lurking in Generic Drugs Manufactured in India

Over the next two posts, we’ll explore a growing international problem involving the safety of generic drugs produced overseas. Namely, generic medications produced in India – including those manufactured by False Claims Act offender Ranbaxy – are becoming more and more problematic, due in part to the alleged falsification of […]
September 7, 2015 Healthcare Fraud

Quest Diagnostics to Pay $1.79 Million to Settle Fraud Claims

Under the guidelines of Medicare Part B, enrollees are entitled to coverage for medically necessary and essential diagnostic services, including bloodwork, x-rays, and similar imaging examinations. If a provider fails to adhere to the Medicare guidelines, it could quickly face liability under the False Claims Act for unlawfully billing the […]
September 4, 2015 Healthcare Fraud

New York Attorney General Announces $8 Million Settlement Over Unlicensed Detox Programs

Following a lengthy investigation by both the state of New York’s Medicaid Fraud Control Unit and the U.S. Attorney’s Office for the Eastern District of New York, several medical corporations operating in the state have agreed to pay $8 million to settle allegations of fraud against Medicaid and Medicare. The […]
August 31, 2015 Healthcare Fraud

Missouri Healthcare Providers Agree to Settle False Claims Act Allegations

When the H.E.A.T. Task Force convened in 2009, part of their mission was to eliminate costly and wasteful kickback schemes from the government-backed healthcare system. Kickback schemes, like the one profiled in today’s case, often involve improper financial arrangements between doctors either pharmaceutical companies or major healthcare corporations. In essence, […]
schedule a free consultation

"*" indicates required fields

By clicking SUBMIT you agree to our Terms of Use and Privacy Policy and you are providing express consent to receive communications from Berger Montague via calls, emails, and/or text messages.

in Settlements & Verdicts
Years of High-Profile Cases
Attorneys Protecting Your Rights
Named “Trial Lawyer of the Year”
States in Which The Firm Has Successfully Litigated Cases

On the Cutting Edge of the Profession

Legal Intelligencer